Stool donation for fecal microbiota transplantation is one of the most rigorously screened forms of human donation in medicine, with acceptance rates that make Ivy League admissions look generous. Studies at major stool banks consistently find that fewer than one in ten applicants make it through the full vetting process, and some programs report acceptance rates as low as about 3%.1PubMed Central. A comprehensive approach to stool donor screening for faecal microbiota transplantation in China The demand for qualified donors is real and growing, though, driven by the procedure’s effectiveness against recurrent gut infections and a wave of research into new applications.
Why Stool Banks Need Donors
Fecal microbiota transplantation, or FMT, works by introducing a healthy community of gut bacteria into a patient whose own microbiome has been disrupted. The primary use is treating recurrent Clostridioides difficile infection, a stubborn and sometimes dangerous gut infection that can resist repeated courses of antibiotics. FMT restores the normal microbial ecosystem through several mechanisms: the transplanted bacteria compete directly with C. difficile for resources, restore bile acid metabolism that keeps the pathogen in check, and help repair the gut’s protective barrier.2PubMed Central. Understanding the mechanisms of faecal microbiota transplantation In a large real-world study, about 79% of patients were cured after one or more FMT treatments.3PubMed. Real-world Effectiveness of Fecal Microbiota Transplantation for First or Second Clostridioides difficile Infection
That high cure rate depends entirely on the quality of the donor material, which is why stool banks invest enormous effort in finding the right people. Unlike blood donation, where a quick questionnaire and a hemoglobin check get you through the door in minutes, stool donor screening involves months of evaluation, repeated lab work, and ongoing monitoring. This selectivity is why programs are perpetually recruiting.
What the Screening Process Looks Like
If you contact a stool bank or FMT center to volunteer, expect a multi-step process that can stretch over several weeks before you’re even provisionally accepted. One widely studied approach uses a four-step protocol: an initial health questionnaire, a clinical interview, blood testing, and direct stool testing that looks for gut pathogens and drug-resistant organisms.4PubMed. Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study Each step is designed to eliminate candidates before the program invests in the more expensive lab work that comes later.
The numbers tell the story of just how hard it is to qualify. A European stool bank that tracked 393 potential donors enrolled only 38 of them, a pass rate of about 10%, and spent over €64,000 on the recruitment and screening process.5PubMed Central. Challenges and costs of donor screening for fecal microbiota transplantations A Chinese program that screened over 2,000 applicants accepted just 66, landing at a 3.2% success rate.6PubMed Central. A comprehensive approach to stool donor screening for faecal microbiota transplantation in China Most people who are turned away fail not because of anything dramatic but because of routine medical history items, medications, or lab results that raise even minor flags.
What Disqualifies You
The exclusion criteria are broader than most prospective donors expect. Obvious disqualifiers include active gastrointestinal symptoms, recent antibiotic use, and known infectious diseases. But the list extends well beyond that. Researchers have recommended excluding people with diabetes, prior cardiovascular events, and recent clinical healthcare exposure until science better understands how these conditions relate to the gut microbiome.7PubMed Central. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review Autoimmune conditions, chronic medication use, recent international travel to regions with endemic tropical infections, and a family history of colorectal cancer or inflammatory bowel disease can all end a candidacy.
Body weight is another area of scrutiny. Although a larger study found that a single FMT from an overweight donor did not change recipient weight trends over time,8Clinical Gastroenterology and Hepatology. Stool Donor Body Mass Index Does Not Affect Recipient Weight After a Single Fecal Microbiota Transplantation for Clostridium difficile Infection a widely cited case report described a woman who developed new-onset obesity after receiving FMT from a healthy but overweight donor.9PubMed Central. Weight gain after fecal microbiota transplantation Most stool banks now set a BMI cutoff to avoid even the theoretical risk of transferring metabolic traits.
Mental health medications present a gray area. Many antidepressants and antipsychotics alter gut motility and microbial composition, which can make an otherwise healthy donor’s microbiome less representative of a truly “healthy” baseline. Programs vary in how strictly they interpret this, but if you take a daily prescription for a psychiatric condition, expect to be asked detailed questions about it.
The “Super Donor” Idea
Not all qualified donors are equal in the eyes of researchers. The concept of a “super donor” refers to individuals whose stool consistently produces better clinical outcomes in recipients, and recent work has started to pin down what makes their microbiomes special. Super donors tend to show significantly higher microbial diversity and distinct compositional profiles, with bacteria like Faecalibacterium and Prevotella making up a meaningful proportion of their gut communities. In one study, seven bacterial species isolated from a super donor all inhibited the growth of C. difficile in lab tests.10PubMed Central. Microbiota Analysis of gut microbiota in super donors for fecal microbiota transplantation and isolated gut commensal bacteria of inhibition against Clostridioides difficile
A detailed case study of one super donor’s microbiome found that Faecalibacterium prausnitzii accounted for about 10% of detected species, alongside substantial proportions of Bacteroides species and a notable presence of Akkermansia muciniphila, a bacterium increasingly linked to gut barrier health.11Frontiers in Microbiomes. Case Report: Oral and fecal microbiota in a super-donor: the healthy microbiota paradigm for fecal transplantation The trouble is that there is no reliable way to predict super-donor status before actually tracking clinical outcomes across multiple recipients. You can have a pristine health profile and high microbial diversity and still produce material that doesn’t perform as well as someone else’s. This unpredictability is one reason programs try to retain donors who show consistent results.
What You Actually Do as a Donor
Once accepted, the daily reality of stool donation is less clinical than the screening process might suggest. You collect samples at home using a provided kit and deliver or ship them to the stool bank within a specified window. Temperature and timing matter for preserving the live bacteria. Studies on handling protocols show that if collection-to-processing time exceeds 24 hours, samples should be kept refrigerated, and ideally they reach the lab within 72 hours.12Scientific Reports. A Guide for Ex Vivo Handling and Storage of Stool Samples Intended for Fecal Microbiota Transplantation The processing itself happens at the lab: the stool is diluted, filtered, and frozen for future use.13PubMed Central. From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation
Donation frequency varies by program, but many stool banks ask for multiple samples per week. The median active participation time in one tracked cohort was 13 months.14PubMed Central. Challenges and costs of donor screening for fecal microbiota transplantations Throughout that period, donors undergo periodic re-screening with blood and stool tests to ensure nothing has changed. A single course of antibiotics for, say, a sinus infection can temporarily disqualify you, and travel to certain parts of the world triggers a waiting period. The commitment is real, and the logistics of regular collection and delivery are among the most commonly cited deterrents for people who are otherwise willing.15PubMed Central. In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation
Diet and Lifestyle Expectations
Stool banks don’t typically dictate a specific meal plan, but they care very much about dietary patterns. Research has increasingly pointed to dietary fiber as a major shaper of gut microbiome composition. Animal studies have shown that a high-fiber diet may play a more important role in the composition of transplanted microbiota than the identity of the donor itself, and human research has echoed this finding.16PubMed Central. The Impact of Diet on the Fecal Microbiota Transplantation Success in Patients with Gastrointestinal Diseases—A Literature Review This means that a donor eating a varied, fiber-rich diet centered on whole grains, vegetables, and legumes is likely producing more therapeutically useful material than someone subsisting on processed food, even if both pass every blood and stool test.
Mouse studies have further demonstrated that the metabolic benefits of a healthy diet and exercise can actually be transferred through FMT, with diet having a stronger influence on the gut microbial profile than exercise alone.17Scientific Reports. Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice While human evidence is still catching up, the practical implication for donors is clear: programs prefer people whose everyday eating habits are already aligned with what produces a robust, diverse microbiome. You probably won’t be told exactly what to eat, but don’t be surprised if your intake of fruits, vegetables, and fermented foods comes up during screening.
Microbiome Stability Over Time
A key reason stool banks re-screen donors periodically is that the gut microbiome does shift over time, even in healthy people. A large longitudinal study tracking nearly a thousand samples over a year found that the gut microbiome remains highly stable for about the first six months, after which measurable drift begins.18PubMed Central. The Human Gut Microbiome Activity Is Resilient and Stable for up to Six Months: A Large Stool Metatranscriptomic Study That drift is gradual and sits on top of a stable baseline, but it means that a sample banked nine months ago is slightly less representative of your current gut state than one collected last week.
Age plays a role too. A study following 81 healthy individuals across different age groups over 12 months found that the teenage cohort showed the highest microbiome stability, with specific genera like Faecalibacterium and Bifidobacterium displaying exceptionally consistent levels over time.19Current Research in Microbial Sciences. Characteristics and longitudinal stability of Gut Microbiota in healthy individuals across different age groups Most stool banks recruit donors in their 20s through 40s as a practical compromise between microbiome maturity and stability. Metagenomic analysis of repeat donations has confirmed that individual donors maintain high temporal consistency, which supports the idea that a qualified donor can keep producing usable material over many months.20bioRxiv. Stability and Processing Impacts on Faecal Microbiota Transplant Products: An Integrated Metagenomic-Culturomic Analysis
Compensation and Motivation
The question everyone asks and few programs are upfront about: yes, stool donors are generally paid. Compensation varies by program and country. In the United States, programs have historically offered anywhere from $25 to $75 per donation, with bonuses for consistency. Given that some programs ask for three to five samples per week, the income can be nontrivial for a committed donor, though it rarely amounts to a primary livelihood.
A multicenter study surveying potential donors found that economic benefit was indeed a motivator, but it ranked alongside altruism, not above it. People who were already blood donors were significantly more likely to consider stool donation, and positive attitudes toward FMT independently increased willingness. The biggest deterrents were the screening process itself, the high frequency of expected donations, and the awkward logistics of collecting and transporting feces.21PubMed Central. In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation The social perception of stool donation also works against recruitment: many people who would happily talk about giving blood at a Red Cross drive are less eager to mention what they do at a stool bank.
The Emotional Side of Being Rejected
Given that the vast majority of applicants don’t make the cut, rejection is the most common donor experience. Research into how people react to being told their stool isn’t wanted found that disappointment and confusion were the most frequent responses.22PubMed. “Why don’t you want my poop?” Willing stool donor’s experiences of being ineligible to donate intestinal microbiota Many volunteers had no idea they had a disqualifying condition. For some, the rejection raised anxiety about their own health, even when the disqualifying factor was something benign like past antibiotic use or a slightly elevated inflammatory marker that meant nothing clinically. Programs that communicate the reasons for rejection clearly and reassure candidates that exclusion does not imply disease tend to produce less lasting frustration.
How Donations Reach Patients
The processed material reaches patients in more than one form, and the choice of delivery route affects how quickly the transplanted bacteria take hold. A randomized trial comparing oral capsules to colonoscopy-delivered FMT found them equally effective for preventing recurrent C. difficile infection, with about 96% success in both groups.23PubMed Central. Effect of Oral Capsule– vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial However, lower endoscopic delivery (through colonoscopy) produces faster initial engraftment of the donor’s bacterial community compared to oral capsules, with the gap evening out after the first couple of weeks.24Scientific Reports. Lower endoscopic delivery of freeze-dried intestinal microbiota results in more rapid and efficient engraftment than oral administration
For donors, this doesn’t change the collection process, but it does mean your single donation may be processed into different formats depending on the receiving center’s protocols. Some material gets encapsulated for oral administration; some is prepared as a liquid suspension for endoscopic delivery. Frozen encapsulated microbiota has been confirmed to be just as effective as other delivery methods for treating recurrent C. difficile infection, which makes banking and shipping logistically simpler.25PubMed Central. Fecal Microbiota Transfer
Geography and the Microbiome
One subtlety that doesn’t get much public attention is how much geography matters in microbiome science. Studies have found pronounced differences in gut bacterial communities between populations in different countries, with diet, environment, and lifestyle all playing roles.26PubMed Central. Human gut microbiome viewed across age and geography Even within a single country, a study of over 7,000 individuals across 14 districts found that location was the strongest predictor of microbiome variation, stronger than any individual health measure. Microbiome-based disease models built in one region failed when applied to people in a different region.27Nature Medicine. Regional variation limits applications of healthy gut microbiome reference ranges and disease models
For stool donation, this means that a donor in rural Sub-Saharan Africa has a profoundly different gut microbial profile than one in suburban Chicago, and neither is inherently better or worse. But it raises unresolved questions about whether donor-recipient geographic matching matters for clinical outcomes. Most FMT trials have been conducted in Western populations using Western donors, so the evidence base is skewed. As FMT programs expand globally, building localized donor pools rather than shipping material across continents may turn out to be important, though the science isn’t settled on this yet.
Synthetic Alternatives on the Horizon
The difficulty of finding, screening, and retaining stool donors has pushed researchers toward an alternative: building bacterial communities from scratch in the lab. Instead of transplanting everything in a donor’s stool, these synthetic consortia contain defined mixtures of specific bacterial species chosen for their therapeutic properties. One group developed a consortium of 13 species isolated from healthy donor stool and tested it directly in patients with C. difficile infection.28PubMed Central. “Bacterial Consortium”: A Potential Evolution of Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection Multiple research teams are now working on similar approaches, motivated by safety concerns around the risk of accidentally transferring drug-resistant organisms or undesirable traits from whole stool.29PubMed Central. Design and application of synthetic human gut microbial communities
The FDA approved the first standardized microbiota product derived from human stool in 2023, representing a step between traditional FMT and fully synthetic alternatives. Regulatory oversight of stool banks and their products has tightened considerably, with requirements around donor screening safety and product standardization becoming more formalized. If synthetic consortia prove effective, they could eventually reduce the need for human stool donors altogether, though that shift is likely years away. In the meantime, researchers have emphasized that novel approaches to designing targeted bacterial cocktails are needed to move the field beyond its dependence on whole donor stool.30PubMed. Design of synthetic microbial consortia for gut microbiota modulation
A Practice That Goes Back Centuries
The idea of using someone else’s gut contents as medicine feels like it should be cutting-edge, but it has surprisingly deep roots. The earliest recorded use dates to fourth-century China, where a physician named Ge Hong administered a fecal slurry called “yellow soup” to treat severe food poisoning and diarrhea. Bedouin groups reportedly consumed camel stool as a remedy for dysentery. Veterinary applications appeared in Europe by the 16th century, and during World War II, German soldiers in North Africa were treated with gut bacteria for dysentery. The first modern medical use came in 1958, when a surgeon used fecal transplantation via enema to treat four patients with severe pseudomembranous colitis, all successfully.31PubMed. Current Evidence in Delivery and Therapeutic Uses of Fecal Microbiota Transplantation in Human Diseases-Clostridium difficile Disease and Beyond What has changed is not the basic intuition that a healthy gut ecosystem can rescue a sick one, but the science and safety infrastructure that now surrounds the practice. The modern stool donor lives inside a system of questionnaires, blood draws, and stool cultures that Ge Hong could never have imagined, all in service of the same fundamental idea.